The value of PET/CT with FES or FDG tracers in metastatic breast cancer: a computer simulation study in ER-positive patients

Koleva-Kolarova, RGGreuter, MJWvan Kruchten, MVermeulen, KMFeenstra, TBuskens, EGlaudemans, AWJMde Vries, EFJde Vries, EGEHospers, GAPde Bock, GH2025-03-252025-03-2520152588000610.1038/bjc.2015.138https://rivm.openrepository.com/handle/10029/649129The value of PET/CT with FES or FDG tracers in metastatic breast cancer: a computer simulation study in ER-positive patientsArticleBr J Cancer 2015; 112(10):1617-252025-03-25